Authors: Kanter-Lewensohn, L Dricu, A Girnita, L Wejde, J Larsson, O

Citation: L. Kanter-lewensohn et al., Expression of insulin-like growth factor-1 receptor (IGF-1R) and p27(Kip1)in melanocytic tumors: A potential regulatory role of IGF-1 pathway in distribution of p27(Kip1) between different cyclins, GROW FACTOR, 17(3), 2000, pp. 193-202

Authors: Kanter-Lewensohn, L Girnita, L Girnita, A Dricu, A Olsson, G Leech, L Nilsson, G Hilding, A Wejde, J Brismar, K Larsson, O

Citation: L. Kanter-lewensohn et al., Tamoxifen-induced cell death in malignant melanoma cells: possible involvement of the insulin-like growth factor-1 (IGF-1) pathway, MOL C ENDOC, 165(1-2), 2000, pp. 131-137

Authors: Girnita, L Wang, M Xie, YT Nilsson, G Dricu, A Wejde, J Larsson, O

Citation: L. Girnita et al., Inhibition of N-linked glycosylation down-regulates insulin-like growth factor-1 receptor at the cell surface and kills Ewing's sarcoma cells: therapeutic implications, ANTI-CAN DR, 15(1), 2000, pp. 67-72

Authors: Girnita, L Girnita, A Brodin, B Xie, YT Nilsson, G Dricu, A Lundeberg, J Wejde, J Bartolazzi, A Wiman, KG Larsson, O

Citation: L. Girnita et al., Increased expression of insulin-like growth factor I receptor in malignantcells expressing aberrant p53: Functional impact, CANCER RES, 60(18), 2000, pp. 5278-5283

Authors: Dricu, A Kanter, L Wang, M Nilsson, G Hjertman, M Wejde, J Larsson, O

Citation: A. Dricu et al., Expression of the insulin-like growth factor 1 receptor (IGF-1R) in breastcancer cells: evidence for a regulatory role of dolichyl phosphate in the transition from an intracellular to an extracellular IGF-1 pathway, GLYCOBIOLOG, 9(6), 1999, pp. 571-579

Authors: Wang, M Xie, YT Girnita, L Nilsson, G Dricu, A Wejde, J Larsson, O

Citation: M. Wang et al., Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells, EXP CELL RE, 246(1), 1999, pp. 38-46